ATE125819T1 - Enzymatischer prozess zur herstellung immunomodulatorischer pentapeptide und intermediate zu deren herstellung. - Google Patents

Enzymatischer prozess zur herstellung immunomodulatorischer pentapeptide und intermediate zu deren herstellung.

Info

Publication number
ATE125819T1
ATE125819T1 AT89300369T AT89300369T ATE125819T1 AT E125819 T1 ATE125819 T1 AT E125819T1 AT 89300369 T AT89300369 T AT 89300369T AT 89300369 T AT89300369 T AT 89300369T AT E125819 T1 ATE125819 T1 AT E125819T1
Authority
AT
Austria
Prior art keywords
amino acid
acid residue
amino
omega
derivative
Prior art date
Application number
AT89300369T
Other languages
English (en)
Inventor
Stig Aasmul-Olsen
Anders J Andersen
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Application granted granted Critical
Publication of ATE125819T1 publication Critical patent/ATE125819T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • C07K14/662Thymopoietins at least 1 amino acid in D-form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT89300369T 1988-01-14 1989-01-16 Enzymatischer prozess zur herstellung immunomodulatorischer pentapeptide und intermediate zu deren herstellung. ATE125819T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK015888A DK15888D0 (da) 1988-01-14 1988-01-14 Enzymatisk fremgangsmaade til fremstilling af immunmodulerende pentapeptider samt mellemprodukter til brug ved fremgangsmaaden

Publications (1)

Publication Number Publication Date
ATE125819T1 true ATE125819T1 (de) 1995-08-15

Family

ID=8090415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89300369T ATE125819T1 (de) 1988-01-14 1989-01-16 Enzymatischer prozess zur herstellung immunomodulatorischer pentapeptide und intermediate zu deren herstellung.

Country Status (9)

Country Link
EP (1) EP0324659B1 (de)
AT (1) ATE125819T1 (de)
AU (1) AU2943989A (de)
DE (1) DE68923625T2 (de)
DK (2) DK15888D0 (de)
ES (1) ES2079374T3 (de)
HU (1) HUT57794A (de)
IT (1) IT1223774B (de)
WO (1) WO1989006656A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461834B1 (en) 1998-11-06 2002-10-08 Bionebraska, Inc. Clostripain catalyzed amidation of peptides
MXPA04007408A (es) * 2003-05-17 2005-08-15 Microsoft Corp Sistema y metodo para proporcionar interpretaciones multiples de contenido de documento.
KR20100058559A (ko) * 2007-09-11 2010-06-03 몬도바이오테크 래보래토리즈 아게 스플레노펜틴 및 티모펜틴의 배합물 및 약제에서 이의 용도
US20100204149A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of octreotide as a therapeutic agent
CA2698980A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
HRP20171478T1 (hr) 2011-01-27 2017-11-17 Neuren Pharmaceuticals Limited Liječenje poremećaja autističnog spektra pomoću glicil-l-2-metilprolil-l-glutaminske kiseline
CN119753067B (zh) * 2024-12-25 2025-12-19 河北保食健健康科技有限公司 一种提高免疫力的小牛胸腺肽及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1184770C2 (de) * 1961-06-01 1965-09-02 Hoffmann La Roche Verfahren zur Herstellung von antibacteriell wirksamen Peptiden
FI40902B (de) * 1962-10-12 1969-03-31 Hoffmann La Roche
JPS5443076B2 (de) * 1974-04-24 1979-12-18
FR2294715A1 (fr) * 1974-12-17 1976-07-16 Inst Rech Scient Nouveau peptide utilisable en therapeutique et son procede d'obtention
FI70597C (fi) * 1979-04-06 1986-09-24 Carlsberg Biotechnology Ltd Foerfarande foer enzymatisk framstaellning av peptider
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
JPS5917997A (ja) * 1982-07-23 1984-01-30 Toyo Soda Mfg Co Ltd ジペプチドエステルとアミノ酸エステルとの付加化合物の製造方法
IT1188645B (it) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica Tripeptide ad attivita' immunostimolante
DE3619633A1 (de) * 1986-06-11 1987-12-17 Hoechst Ag Peptide mit einfluss auf die diurese und natriurese, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung

Also Published As

Publication number Publication date
WO1989006656A1 (en) 1989-07-27
DE68923625D1 (de) 1995-09-07
HU890937D0 (en) 1991-11-28
AU2943989A (en) 1989-08-11
HUT57794A (en) 1991-12-30
DK15888D0 (da) 1988-01-14
DK169090D0 (da) 1990-07-13
DK169090A (da) 1990-09-14
ES2079374T3 (es) 1996-01-16
EP0324659A3 (de) 1991-04-03
EP0324659B1 (de) 1995-08-02
DE68923625T2 (de) 1996-03-28
IT1223774B (it) 1990-09-29
EP0324659A2 (de) 1989-07-19
IT8867761A0 (it) 1988-08-12

Similar Documents

Publication Publication Date Title
EP0017485B1 (de) Verfahren zur enzymatischen Herstellung von Peptiden
WO1995020039B1 (en) Customized proteases with altered transacylation activity
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
WO2005027953A3 (en) Use of proline specific endoproteases to hydrolyse peptides and proteins
US4086136A (en) Process for producing a peptide using a serine or thiol proteinase
WO1995020039A3 (en) Customized proteases with altered transacylation activity
EP1005526A4 (de) Direkte expression von peptiden ins kulturmedium.
TW242165B (de)
ATE125819T1 (de) Enzymatischer prozess zur herstellung immunomodulatorischer pentapeptide und intermediate zu deren herstellung.
DE69739013D1 (de) Verfahren zur Herstellung sekretorischer KEX2-Derivate
Shui-Tein et al. Stable industrial protease catalyzed peptide bond formation in organic solvent.
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
AU589289B2 (en) Novel inhibitor peptides
CA1059938A (en) Process for producing a peptide
ATE101616T1 (de) Verfahren zur herstellung von dipeptiden.
EP0945512A3 (de) Serinproteasen
Shibata et al. A novel type of substrate specificity of rice BAPAase (benzoyl-L-arginine p-nitroanilide hydrolase) with mixed endopeptidase and carboxypeptidase
NO157706B (no) Fremgangsmÿte for enzymatisk fremstilling av peptider.
IT1214410B (it) Metodo di ottenimento di n-formil-l-peptidi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time